• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体功能障碍、心血管疾病与中医之间的关联

Correlation between Mitochondrial Dysfunction, Cardiovascular Diseases, and Traditional Chinese Medicine.

作者信息

Zhu Li, Chen Zhigang, Han Keli, Zhao Yilin, Li Yan, Li Dongxu, Wang Xiulong, Li Xuefang, Sun Siyu, Lin Fei, Zhao Guoan

机构信息

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.

Henan Joint International Research Laboratory of Cardiovascular Injury and Repair, Xinxiang, Henan, China.

出版信息

Evid Based Complement Alternat Med. 2020 Oct 7;2020:2902136. doi: 10.1155/2020/2902136. eCollection 2020.

DOI:10.1155/2020/2902136
PMID:33101442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568168/
Abstract

Cardiovascular disease (CVD) is the number one threat that seriously endangers human health. However, the mechanism of their occurrence is not completely clear. Increasing studies showed that mitochondrial dysfunction is closely related to CVD. Possible causes of mitochondrial dysfunction include oxidative stress, Ca disorder, mitochondrial DNA mutations, and reduction of mitochondrial biosynthesis, all of which are closely related to the development of CVD. At present, traditional Chinese medicine (TCM) is widely used in the treatment of CVD. TCM has the therapeutic characteristics of multitargets and multipathways. Studies have shown that TCM can treat CVD by protecting mitochondrial function. Via systematic literature review, the results show that the specific mechanisms include antioxidant stress, regulation of calcium homeostasis, antiapoptosis, and regulation of mitochondrial biosynthesis. This article describes the relationship between mitochondrial dysfunction and CVD, summarizes the TCM commonly used for the treatment of CVD in recent years, and focuses on the regulatory effect of TCM on mitochondrial function.

摘要

心血管疾病(CVD)是严重危害人类健康的首要威胁。然而,其发病机制尚不完全清楚。越来越多的研究表明,线粒体功能障碍与心血管疾病密切相关。线粒体功能障碍的可能原因包括氧化应激、钙紊乱、线粒体DNA突变和线粒体生物合成减少,所有这些都与心血管疾病的发展密切相关。目前,中医药广泛应用于心血管疾病的治疗。中医药具有多靶点、多途径的治疗特点。研究表明,中医药可通过保护线粒体功能来治疗心血管疾病。通过系统的文献综述,结果表明其具体机制包括抗氧化应激、调节钙稳态、抗凋亡和调节线粒体生物合成。本文阐述了线粒体功能障碍与心血管疾病之间的关系,总结了近年来常用于治疗心血管疾病的中医药,并重点探讨了中医药对线粒体功能的调节作用。

相似文献

1
Correlation between Mitochondrial Dysfunction, Cardiovascular Diseases, and Traditional Chinese Medicine.线粒体功能障碍、心血管疾病与中医之间的关联
Evid Based Complement Alternat Med. 2020 Oct 7;2020:2902136. doi: 10.1155/2020/2902136. eCollection 2020.
2
Cardiovascular disease treatment using traditional Chinese medicine:Mitochondria as the Achilles' heel.使用中医药治疗心血管疾病:线粒体是阿喀琉斯之踵。
Biomed Pharmacother. 2023 Aug;164:114999. doi: 10.1016/j.biopha.2023.114999. Epub 2023 Jun 11.
3
Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine.心血管疾病、线粒体与传统中医
Evid Based Complement Alternat Med. 2015;2015:143145. doi: 10.1155/2015/143145. Epub 2015 May 17.
4
[Precise application of Traditional Chinese Medicine in minimally-invasive techniques].[中医在微创技术中的精准应用]
Zhongguo Gu Shang. 2018 Jun 25;31(6):493-496. doi: 10.3969/j.issn.1003-0034.2018.06.001.
5
Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases.肠道黏膜屏障:中药治疗心血管疾病的潜在靶点。
Front Pharmacol. 2024 Feb 26;15:1372766. doi: 10.3389/fphar.2024.1372766. eCollection 2024.
6
Effect of Traditional Chinese Medicine on the Cardiovascular Diseases.中药对心血管疾病的影响。
Front Pharmacol. 2022 Mar 21;13:806300. doi: 10.3389/fphar.2022.806300. eCollection 2022.
7
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
8
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.用于治疗骨质疏松症的中药方剂:对抗骨质疏松药物发现的启示。
J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11.
9
[Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine].[线粒体功能障碍在糖尿病心肌病中的作用及中医药干预]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):8-14. doi: 10.19540/j.cnki.cjcmm.20171027.014.
10
Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies.应用蛋白质组学确定中药疗法的作用机制。
J Ethnopharmacol. 2014 Aug 8;155(1):1-8. doi: 10.1016/j.jep.2014.05.022. Epub 2014 May 24.

引用本文的文献

1
Mitochondrial dysfunction as a central hub linking Na/Ca homeostasis and inflammation in ischemic arrhythmias: therapeutic implications.线粒体功能障碍作为缺血性心律失常中连接钠/钙稳态与炎症的核心枢纽:治疗意义
Front Cardiovasc Med. 2025 Aug 12;12:1506501. doi: 10.3389/fcvm.2025.1506501. eCollection 2025.
2
Cardiovascular protection of YiyiFuzi powder and the potential mechanisms through modulating mitochondria-endoplasmic reticulum interactions.益气温阳方对心血管的保护作用及其通过调节线粒体-内质网相互作用的潜在机制
Front Pharmacol. 2024 Jun 24;15:1405545. doi: 10.3389/fphar.2024.1405545. eCollection 2024.
3
SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.SIRT6 在调控线粒体损伤及相关心脏功能障碍中的作用:CVD 的一个潜在治疗靶点。
Cardiovasc Toxicol. 2024 Jun;24(6):598-621. doi: 10.1007/s12012-024-09858-1. Epub 2024 Apr 30.
4
Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management.草药与肠道微生物群:探索神经退行性疾病管理中未被挖掘的治疗潜力。
Arch Pharm Res. 2024 Feb;47(2):146-164. doi: 10.1007/s12272-023-01484-9. Epub 2024 Jan 15.
5
Protective effect and mechanism of different proportions of "" herb pair on ischemic heart disease.不同比例“药对”对缺血性心脏病的保护作用及机制
Heliyon. 2023 Nov 10;9(11):e22150. doi: 10.1016/j.heliyon.2023.e22150. eCollection 2023 Nov.
6
Real-Time Measurement of the Mitochondrial Bioenergetic Profile of Neutrophils.实时测量中性粒细胞的线粒体生物能量特征。
J Vis Exp. 2023 Jun 2(196). doi: 10.3791/64971.
7
The Role of Bile Acids in the Human Body and in the Development of Diseases.胆汁酸在人体和疾病发展中的作用。
Molecules. 2022 May 25;27(11):3401. doi: 10.3390/molecules27113401.
8
Danggui Buxue Decoction Ameliorates Idiopathic Pulmonary Fibrosis through MicroRNA and Messenger RNA Regulatory Network.当归补血汤通过微小RNA和信使核糖核酸调控网络改善特发性肺纤维化
Evid Based Complement Alternat Med. 2022 Apr 26;2022:3439656. doi: 10.1155/2022/3439656. eCollection 2022.
9
Myocardial protective effect and transcriptome profiling of Naoxintong on cardiomyopathy in zebrafish.脑心通对斑马鱼心肌病的心肌保护作用及转录组分析
Chin Med. 2021 Nov 14;16(1):119. doi: 10.1186/s13020-021-00532-0.

本文引用的文献

1
Analysis of the Molecular Mechanism of Acute Coronary Syndrome Based on circRNA-miRNA Network Regulation.基于circRNA-miRNA网络调控的急性冠状动脉综合征分子机制分析
Evid Based Complement Alternat Med. 2020 Apr 29;2020:1584052. doi: 10.1155/2020/1584052. eCollection 2020.
2
Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine.中药治疗冠心病中circRNA-miRNA-mRNA网络的研究进展
Evid Based Complement Alternat Med. 2020 Feb 17;2020:8048691. doi: 10.1155/2020/8048691. eCollection 2020.
3
Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis.年龄相关的线粒体功能障碍加速动脉粥样硬化形成。
Circ Res. 2020 Jan 31;126(3):298-314. doi: 10.1161/CIRCRESAHA.119.315644. Epub 2019 Dec 9.
4
Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop.解锁心血管系统中线粒体的秘密:心力衰竭治疗的新途径——2018 年美国国家心肺血液研究所研讨会报告。
Circulation. 2019 Oct 1;140(14):1205-1216. doi: 10.1161/CIRCULATIONAHA.119.040551.
5
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.线粒体作为动脉粥样硬化治疗的选择性靶标:线粒体 DNA 突变和有缺陷的线粒体自噬在动脉粥样硬化和慢性炎症发病机制中的作用。
Curr Neuropharmacol. 2020;18(11):1064-1075. doi: 10.2174/1570159X17666191118125018.
6
Mitochondria and Cardiovascular Disease: A Brief Account.线粒体与心血管疾病:简要概述
Crit Rev Eukaryot Gene Expr. 2019;29(4):295-304. doi: 10.1615/CritRevEukaryotGeneExpr.2019028579.
7
Mitochondria as multifaceted regulators of cell death.线粒体作为细胞死亡的多面调节者。
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100. doi: 10.1038/s41580-019-0173-8. Epub 2019 Oct 21.
8
Emerging role of mitophagy in cardiovascular physiology and pathology.线粒体自噬在心血管生理学和病理学中的新作用。
Mol Aspects Med. 2020 Feb;71:100822. doi: 10.1016/j.mam.2019.09.006. Epub 2019 Oct 3.
9
Mitochondrial dynamics modulation as a critical contribution for Shenmai injection in attenuating hypoxia/reoxygenation injury.线粒体动态调节作为参麦注射液减轻缺氧/复氧损伤的关键贡献。
J Ethnopharmacol. 2019 Jun 12;237:9-19. doi: 10.1016/j.jep.2019.03.033. Epub 2019 Mar 14.
10
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study.通心络胶囊干预颈动脉斑块的随机、双盲、平行对照、多中心临床研究(CAPITAL)
Sci Rep. 2019 Mar 14;9(1):4545. doi: 10.1038/s41598-019-41118-z.